Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 90634

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
July 19, 2022
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Strides Pharma Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-785-06.

D-1330-2022
Recall number
D-1330-2022
Initiated
July 19, 2022
Classification
Class II
Status
Terminated
Recalling firm
Strides Pharma Inc.
Quantity
1032 bottles

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
foreign tablet

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets

Code information

Lot #: 7248988B, Exp 9/2023

Distribution pattern

US Nationwide